Spero Therapeutics (SPRO) Revenue Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.82% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 19.04% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 3,790.58% |
| 10 | Spero Therapeutics | 154.37 Mn | 98.24 Mn | - | -95.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95.61% |
| Dec 31, 2025 | -124.29% |
| Sep 30, 2025 | 8,272.31% |
| Jun 30, 2025 | 140.37% |
| Mar 31, 2025 | -36.61% |
| Dec 31, 2024 | -53.84% |
| Sep 30, 2024 | -70.18% |
| Jun 30, 2024 | 117.34% |
| Mar 31, 2024 | 4,055.61% |
| Dec 31, 2023 | 290.72% |
| Sep 30, 2023 | -89.13% |
| Jun 30, 2023 | 36.28% |
| Mar 31, 2023 | -89.22% |
| Dec 31, 2022 | 8.63% |
| Sep 30, 2022 | 183.33% |
| Jun 30, 2022 | -5.37% |
| Mar 31, 2022 | -71.66% |
| Sep 30, 2021 | 1,763.16% |
| Jun 30, 2021 | 21.95% |
| Mar 31, 2021 | 329.16% |
| Sep 30, 2020 | -99.18% |
| Jun 30, 2020 | 2,477.61% |
| Mar 31, 2020 | -77.96% |
| Dec 31, 2019 | -58.87% |
| Sep 30, 2019 | 605.62% |
| Jun 30, 2019 | -85.53% |
| Dec 31, 2018 | 70.39% |
| Sep 30, 2018 | 10.22% |
| Jun 30, 2018 | 85.94% |
| Dec 31, 2017 | 1,627.69% |
| Sep 30, 2017 | 497.00% |